AI Engines For more Details: Perplexity Kagi Labs You
Hypertension (High Blood Pressure):
Tobacco Dependence:
Dosage and Administration:
Side Effects:
Contraindications:
Drug Interactions:
Monitoring:
Rank | Probiotic | Impact |
---|---|---|
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
ADHD | 0.3 | 0.3 | 0 |
Allergic Rhinitis (Hay Fever) | 0.6 | 0.4 | 0.5 |
Allergies | 1.5 | 0.9 | 0.67 |
Allergy to milk products | 0.7 | 0.6 | 0.17 |
Alzheimer's disease | 1.2 | 1.4 | -0.17 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | 0.7 | -0.17 |
Ankylosing spondylitis | 0.9 | 0.3 | 2 |
Anorexia Nervosa | 0.3 | 0.3 | 0 |
Antiphospholipid syndrome (APS) | 0.4 | 0.3 | 0.33 |
Asthma | 0.9 | 0.9 | |
Atherosclerosis | 0.7 | 0.7 | |
Atrial fibrillation | 0.3 | 0.9 | -2 |
Autism | 1.7 | 1.5 | 0.13 |
Autoimmune Disease | 0.6 | 0.6 | |
benign prostatic hyperplasia | 0.6 | 0.6 | |
Biofilm | 0.4 | 0.4 | |
Bipolar Disorder | 1.5 | 0.6 | 1.5 |
Brain Trauma | 0.3 | -0.3 | |
Breast Cancer | 0.4 | 0.4 | |
Cancer (General) | 0.3 | -0.3 | |
Carcinoma | 1.5 | 0.3 | 4 |
Celiac Disease | 0.4 | 0.6 | -0.5 |
Cerebral Palsy | 0.3 | -0.3 | |
Chronic Fatigue Syndrome | 2.1 | 0.8 | 1.63 |
Chronic Kidney Disease | 0.9 | 0.3 | 2 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.4 | 0.4 | |
Chronic Urticaria (Hives) | 0.9 | 0.9 | |
Coagulation / Micro clot triggering bacteria | 0.9 | 0.3 | 2 |
Cognitive Function | 0.3 | 0.3 | |
Colorectal Cancer | 1.3 | 0.4 | 2.25 |
Constipation | 0.9 | 0.9 | |
Coronary artery disease | 1.3 | 1.3 | |
COVID-19 | 2.1 | 1.2 | 0.75 |
Crohn's Disease | 1.8 | 0.3 | 5 |
cystic fibrosis | 0.9 | 0.9 | |
d-lactic acidosis (one form of brain fog) | 0.4 | 0.4 | |
deep vein thrombosis | 0.9 | 0.3 | 2 |
Depression | 2.6 | 1.2 | 1.17 |
Eczema | 0.6 | 0.6 | |
Endometriosis | 0.9 | 0.7 | 0.29 |
Epilepsy | 0.9 | 0.9 | |
erectile dysfunction | 0.6 | 0.6 | |
Fibromyalgia | 0.3 | 0.3 | |
Functional constipation / chronic idiopathic constipation | 1.3 | 0.3 | 3.33 |
gallstone disease (gsd) | 1.3 | 1.3 | |
Generalized anxiety disorder | 1.2 | 1.2 | |
Gout | 0.3 | 0.3 | |
Graves' disease | 0.3 | 0.3 | 0 |
Hashimoto's thyroiditis | 0.3 | 0.3 | 0 |
Heart Failure | 1.3 | 0.3 | 3.33 |
Hidradenitis Suppurativa | 0.3 | 0.3 | |
High Histamine/low DAO | 0.4 | 0.3 | 0.33 |
hypercholesterolemia (High Cholesterol) | 0.4 | 0.4 | |
hyperglycemia | 0.9 | 0.9 | |
Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
hypersomnia | 0.3 | -0.3 | |
hypertension (High Blood Pressure | 0.9 | 0.6 | 0.5 |
Hypothyroidism | 0.3 | -0.3 | |
Hypoxia | 0.9 | 0.9 | |
IgA nephropathy (IgAN) | 0.6 | 0.6 | |
Inflammatory Bowel Disease | 1.8 | 1.8 | 0 |
Insomnia | 0.3 | -0.3 | |
Intelligence | 0.4 | 0.4 | |
Intracranial aneurysms | 0.3 | 0.3 | |
Irritable Bowel Syndrome | 1.3 | 0.3 | 3.33 |
ischemic stroke | 0.7 | 0.6 | 0.17 |
Liver Cirrhosis | 1.8 | 0.9 | 1 |
Long COVID | 0.9 | 1.2 | -0.33 |
Lung Cancer | 0.9 | 0.3 | 2 |
Lymphoma | 0.6 | 0.6 | |
Mast Cell Issues / mastitis | 0.6 | 0.3 | 1 |
ME/CFS without IBS | 0.8 | 0.8 | |
Metabolic Syndrome | 2.4 | 0.6 | 3 |
Mood Disorders | 2.3 | 1.4 | 0.64 |
Multiple Sclerosis | 2 | 0.3 | 5.67 |
Multiple system atrophy (MSA) | 0.3 | -0.3 | |
myasthenia gravis | 0.6 | 0.6 | |
neuropathic pain | 0.3 | 0.3 | |
Neuropathy (all types) | 0.3 | 0.6 | -1 |
neuropsychiatric disorders (PANDAS, PANS) | 0.4 | 0.4 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.3 | 0.3 | 3.33 |
NonCeliac Gluten Sensitivity | 0.3 | 0.3 | |
Obesity | 1.5 | 0.8 | 0.88 |
obsessive-compulsive disorder | 1.5 | 1.5 | |
Osteoarthritis | 0.6 | 0.3 | 1 |
Osteoporosis | 1.2 | 1.2 | |
Parkinson's Disease | 2.1 | 0.9 | 1.33 |
Polycystic ovary syndrome | 1.5 | 1.2 | 0.25 |
Primary sclerosing cholangitis | 0.3 | -0.3 | |
Psoriasis | 0.7 | 0.7 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.1 | 2.1 | |
Rosacea | 0.3 | 0.3 | |
Schizophrenia | 0.9 | 0.3 | 2 |
scoliosis | 0.4 | 0.6 | -0.5 |
Sjögren syndrome | 0.6 | 0.6 | |
Sleep Apnea | 0.3 | 0.6 | -1 |
Slow gastric motility / Gastroparesis | 0.7 | 0.7 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.4 | 0.4 | |
Stress / posttraumatic stress disorder | 0.4 | 0.5 | -0.25 |
Systemic Lupus Erythematosus | 1.2 | 0.3 | 3 |
Tic Disorder | 0.3 | 0.3 | |
Type 1 Diabetes | 1.2 | 0.3 | 3 |
Type 2 Diabetes | 1.8 | 0.7 | 1.57 |
Ulcerative colitis | 1 | 0.6 | 0.67 |
Unhealthy Ageing | 0.6 | 0.6 | |
Vitiligo | 0.3 | 0.3 |